Delivery Order SPE2DB24D2216-SPE2DB25FGPJR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a ceiling value of $4,048.75. This delivery order represents a firm fixed price contract with no set-aside designation, indicating it was awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) with a ceiling value of $1,075.65. This competitive award, issued on July 21, 2025, represents a firm fixed-price delivery order with a completion date of July 22, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count) with a ceiling value of $5,968.23. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 11, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a contract ceiling value of $3,305.63. This is a firm fixed-price delivery order executed without a set-aside designation, indicating competitive award through open procurement. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count) on July 31, 2025, with a firm fixed price ceiling value of $9,931.33 and an ultimate completion date of August 1, 2025. This is a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), a $999.99 billion pharmaceutical prime vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a ceiling value of $1,011.63. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set for ultimate completion on July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,371.82 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count units). This award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) valued at $28,718.73. This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by August 4, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,386.66 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count containers). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for ultimate completion on July 23, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 10 mg capsules (30-count) valued at $2,191.03 under a firm fixed price contract. The award was executed on August 4, 2025, with an ultimate completion date of August 5, 2025, and the product will be performed and delivered from the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-competitive, non-set-aside procurement executed through...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPJRDelivery Order
The Defense Logistics Agency awarded a $1,670.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count units) on August 1, 2025, with an ultimate completion date of August 4, 2025. This delivery order represents a child contract with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As a competitively awarded non-set-aside contractor, the company demonstrates substantial capability in fulfilling diverse pharmaceutical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for the cardiac medication carvedilol exemplifies the company's role in supporting the broader DLA medical supply chain and the planned Pharmaceutical Prime Vendor Global Program Generation V initiative.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/1/25 |